KangMa-Healthcode, Innovates Protein Technology and Changes the Future of Biological Industry. KangMa-Healthcode, since 2015, is a biomedical manufacturing enterprise integrating DNA-to-Protein (D2P) core technology, Biomedical innovative product research and development, and Protein sequence intelligent algorithm. KansetinTM Blocking Protein is one of the industrialization achievements of KangMa D2P technology. KangMa has achieved large scale protein synthesis, and is widely used in IVD, drug screening, biomedicine, public epidemic prevention, medical beauty, health and other fields

KansetinTM Protein Antiviral Nasal Spray provides a pure biological protective barrier by blocking coronaviruses. Contains KansetinTM Protein, shown in laboratory providing effective treatment when administered up to 12 hours after exposure, but without completely avoiding the risk of infection. KansetinTM Protein binds and blocks coronaviruses immediately and inactivates >99.9% of coronaviruses. KansetinTM can be used anywhere, anytime in combination with social distancing, hand washing, face masks, vaccination, and other public health measures